Company intelligence / Profile preview

EnsoData

Madison, Wisconsin, United States

Ownership: Private
Employees: ~60
Development stage: Other

Overview

EnsoData’s FDA-cleared AI platform processes raw data from polysomnography, home sleep tests, and wearables (with photoplethysmography sensors), enabling rapid, accurate diagnosis of sleep apnea and other sleep disorders, impacting over 2.5 million patients and supporting ~75,000+ unique patient analyses monthly; deployments are active in leading US health systems and commercial partnerships have extended solution reach, with the most recent FDA clearance in 2024 enabling diagnosis from consumer wearables[1][2][3][5].

Therapeutic areas: CardiovascularPulmonologyNeurology
Modalities: DeviceSoftware as a Medical Device
Industry: Digital Health Medical Devices

Partnerships

Nonin MedicalHappy HealthCommonSpirit HealthNorthwell HealthRush University Health SystemSanford Health

Beyond the preview

Go deeper on EnsoData.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EnsoData.

Explore the full profile